English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Friday, November 4, 2022
中国抗体宣布委任王善春先生为中国区总裁
中國抗體宣佈委任王善春先生為中國區總裁
SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company
Tuesday, October 18, 2022
访中国抗体制药创办人梁瑞安:现是香港发展创科最好时候
訪中國抗體製藥創辦人梁瑞安:現是香港發展創科最好時候
Wednesday, August 24, 2022
中国抗体宣布SN1011针对视神经脊髓炎谱系疾病的新药研究申请获国家药监局批准
中國抗體宣佈SN1011針對視神經脊髓炎譜系疾病的新藥研究申請獲國家藥監局批准
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA
Friday, July 8, 2022
SinoMab Received the Highest Subsidy from HKSTP
中国抗体获香港科学园最高专项补贴

Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575